Evidence map›Paper›PMID 31086566›Full record

ArticleBiotechnology for biofuels2019

Statistical prediction of interactions between low concentrations of inhibitors on yeast cells responses added to the SD-medium at low pH values.

Cecilia Laluce, Longinus I Igbojionu, José L Silva, Clóvis A Ribeiro

Abstract read
In one paragraph

Article in Biotechnology for biofuels, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. A LignocellulolyticJournal of fungi (Basel, Switzerland) · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cecilia Laluce1Institute of Research in Bioenergy (IPBEN), Institute of Chemistry, São Paulo State University (UNESP), R. Prof. Francisco Degni, 55, Araraquara, SP CEP 14800-060 Brazil.ORCID 0000-0002-2462-7997
Longinus I Igbojionu1Institute of Research in Bioenergy (IPBEN), Institute of Chemistry, São Paulo State University (UNESP), R. Prof. Francisco Degni, 55, Araraquara, SP CEP 14800-060 Brazil.
José L Silva1Institute of Research in Bioenergy (IPBEN), Institute of Chemistry, São Paulo State University (UNESP), R. Prof. Francisco Degni, 55, Araraquara, SP CEP 14800-060 Brazil.
Clóvis A Ribeiro2Dept Analytical Chemistry, Institute of Chemistry, State University of São Paulo, Júlio de Mesquita Filho-UNESP, R. Professor Francisco Degni, 55, Araraquara, São Paulo CEP 14800-060 Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the present work, the main inhibitors of the yeast cells (vanillin, furfural, formic, and levulinic acid) were generated by pretreatments or hydrolysis (sulfuric acid or enzymes) to convert reducing sugars into ethanol. Inhibitors were added at increasing concentrations to the SD-medium containing yeast extract while negative effects on yeast cells were observed. Statistical analyses were applied to predict and interpret results related to biomass production.

resultsInhibitors affected productivities and yields of biomass and ethanol when added to SD-medium. Based on the 2

conclusionsStatistical analysis is an extremely useful tool for predicting data during process monitoring, while re-adjustments of conditions can be performed, whenever necessary. In addition, the development of new strains of yeast with high tolerance to biomass inhibitors will have a major impact on the production of second-generation ethanol. Increases in fermentation activity of the yeast

Indexed as

Biomass inhibitorsFactorial designsInteractions between inhibitorsResponse optimizerRMS analysisSaccharomyces cerevisiae

Identifiers

PMID31086566
PMCPMC6507146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.